“The marketing authorization of MYLOTARG provides a much-needed treatment option offering renewed hope for many acute myeloid leukemia patients in Europe,” said Andreas Penk, M.D., regional president, Pfizer Oncology.
Pfizer Inc. (NYSE:PFE) today announced that it received a Complete Response Letter (CRL) from the United States Food and Drug Administration (FDA) in response to the Biologics License Application for the company’s proposed trastuzumab biosimilar.
Chadwick Matlin, a staff writer for the evidence-based fivethirtyeight.com, recently revealed his unexpected discovery of solace in the practice of mindfulness after experiencing initial skepticism – especially given the practice’s highly trending profile of late.
Researchers at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center and the Memorial Sloan Kettering Cancer Center recently sought to understand the subtleties involved in individuals’ response to cancer.
Younger individuals with a history of stroke should be screened for a specific congenital cardiac anomaly, a neurologist from Weill Cornell Medical Center and NewYork-Presbyterian Hospital recently wrote.
Restrictions placed on Bristol-Myers Squibb studies investigating regimens combining Opdivo (nivolumab) with existing treatments for previously unresponsive multiple myeloma cases have been partially rescinded by the Food and Drug Administration (FDA).
Seattle Genetics and Bristol-Myers Squibb revealed provisional results from their study considering the potential combination of Adcetris (brentuximab vedotin) and Opdivo (nivolumab) in treating relapsed or refractory Hodgkin lymphoma.
A number of organizations recently started an initiative to help the almost 7 million U.S. residents with atrial fibrillation (AF) not caused by heart valve issues understand their increased risk of stroke.
Trainees are being sought for a National Heart, Lung, and Blood Institute-funded T32 training grant program in obesity and cardiovascular disease at the Washington University School of Medicine in St. Louis.